| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9554 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.6666 |
| P-glycoprotein Substrate | Substrate | 0.6137 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6469 |
| Non-inhibitor | 0.5491 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7048 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6944 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8272 |
| CYP450 2D6 Substrate | Non-substrate | 0.9246 |
| CYP450 3A4 Substrate | Substrate | 0.6651 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6330 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9147 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9326 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7996 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7639 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8654 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8797 |
| Non-inhibitor | 0.8312 |
| AMES Toxicity | Non AMES toxic | 0.9692 |
| Carcinogens | Non-carcinogens | 0.9495 |
| Fish Toxicity | High FHMT | 0.9857 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9012 |
| Honey Bee Toxicity | High HBT | 0.8454 |
| Biodegradation | Not ready biodegradable | 0.9382 |
| Acute Oral Toxicity | III | 0.8062 |
| Carcinogenicity (Three-class) | Non-required | 0.5125 |